Table I.
Details of parameters in the study cohort.
| Total study cohort | ||
|---|---|---|
| Parameters | n | % |
| Sex | ||
| Male | 49 | 77.8 |
| Female | 14 | 22.2 |
| Age, years | ||
| ≤50 | 8 | 12.7 |
| >50 | 55 | 87.3 |
| Tumor size | ||
| ≤5 cm | 39 | 61.9 |
| >5 cm | 24 | 38.1 |
| Nerve invasion | ||
| Yes | 25 | 39.7 |
| No | 38 | 60.3 |
| Tumor thrombus | ||
| Yes | 22 | 34.9 |
| No | 41 | 65.1 |
| Nodal metastasis | ||
| Yes | 36 | 57.1 |
| No | 27 | 42.9 |
| Histological grade | ||
| I–II | 30 | 47.6 |
| III | 33 | 52.4 |
| pTN stage | ||
| I | 23 | 36.5 |
| II | 13 | 20.6 |
| III | 27 | 42.9 |
| TILs | ||
| High | 44 | 69.8 |
| Low | 19 | 30.2 |
| TLSs | ||
| High | 43 | 68.3 |
| Low | 20 | 31.7 |
| TILs and TLSs | ||
| High | 32 | 50.8 |
| Low | 31 | 49.2 |
| gcCD8+ TILsa | ||
| High | 23 | 41.8 |
| Low | 32 | 58.2 |
a
gcCD8+ TILs were obtained in 55 patients. TILs, tumor infiltrating lymphocytes; TLSs, tertiary lymphoid structures.